Product Images Simvastatin
View Photos of Packaging, Labels & Appearance
- Footnote for Table 3 - Footnote for Table 3
- Label - lbl636291197
- Figure 9 - simvastatin 10
- table2 - simvastatin 2
- Structure - simvastatin 3
- table 3 - simvastatin 4
- table 4 - simvastatin 5
- Figure 5 - simvastatin 6
- Figure 6 - simvastatin 7
- Figure 7 - simvastatin 8
- Figure 8 - simvastatin 9
- table 1 - table1
Product Label Images
The following 12 images provide visual information about the product associated with Simvastatin NDC 63629-1197 by Bryant Ranch Prepack, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Footnote for Table 3 - Footnote for Table 3
The text describes the results of a chemical assay on Simvastatin acid and its potential interactions with several CYP3Ad inhibitors such as Ketoconazole, erythromycin, clarithromycin, HIV protease inhibitors, and nefazodone. It also explains that the effect of varying amounts of grapefruit juice on Simvastatin pharmacokinetics has not been studied. Two studies were conducted administering grapefruit juice in double-strength and single-strength dosages for a period of 2-3 days along with single dose simvastatin. Overall, the text provides information on potential drug interactions and the need for further research on grapefruit juice consumption while taking Simvastatin.*
Label - lbl636291197
NILD Pharmaceuticals produces Simvastatin tablets with a dosage of 10mg. The medication should be kept out of the reach of children and stored at 20°-25°C. It should be dispensed in a tightly closed and light-resistant container with a child-resistant closure. The product comes in a pack of 1000 tablets and has an NDC number of 63629-1197-1.*
Figure 9 - simvastatin 10
table2 - simvastatin 2
This is a table showing the adverse reactions that were reported by patients treated with Simvastatin and Placebo. The adverse reactions are categorized based on the body system affected. The percentage of patients who experienced these reactions is also provided for both Simvastatin and Placebo. Some of the adverse reactions reported for Simvastatin include Edema/sweling, Constipation, Myalgia, and Eczema. Some of the adverse reactions reported for Placebo include Edema/sweling, Abdominal pain, and Sinusitis.*
Structure - simvastatin 3
table 3 - simvastatin 4
table 4 - simvastatin 5
Figure 5 - simvastatin 6
This appears to be a table showing the number of major vascular and coronary events in patients taking Simvastatin vs. placebo, grouped by various characteristics such as pre-existing peripheral vascular disease. The table also displays risk ratios with confidence intervals.*
Figure 6 - simvastatin 7
Figure 7 - simvastatin 8
Figure 8 - simvastatin 9
table 1 - table1
The text describes a table of drug interactions that may increase the risk of myopathy or rhabdomyolysis. It lists interacting agents and provides prescribing recommendations for each. Some of the agents mentioned are strong CYP3A4 inhibitors, HIV protease inhibitors, cyclosporine, and daptomycin. It also advises not to exceed a certain dose of simvastatin when taking verapamil, diltiazem, amiodarone, or amlodipine. Lastly, the text recommends avoiding grapefruit juice and provides a contraindication for lamotrigine.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
